Muhie Oumer Abdu, Adera Haylemariam, Tsige Eyob, Afework Aschalew
Department of Internal Medicine, GAMBY Teaching General Hospital, Bahir Dar, Ethiopia.
Department of Public Health, GAMBY Teaching General Hospital, Bahir Dar, Ethiopia.
Int Med Case Rep J. 2021 Dec 1;14:819-821. doi: 10.2147/IMCRJ.S345288. eCollection 2021.
Herpes zoster is a reactivation of varicella zoster virus infection. We presented this case since it occurred after the receipt of Covaxin vaccine. There are few case reports of herpes zoster after the receipt of COVID-19 vaccine in the literature.
We presented a case of herpes zoster in a 72-year-old lady after she received the first dose of the vaccine for COVID-19. She had post-herpetic neuralgia.
It is evident that VZV reactivation is one of the untoward events of the COVID-19 vaccine. However, it is wise to do large epidemiologic studies to check how common herpes zoster is after the receipt of COVID-19 vaccine.
带状疱疹是水痘-带状疱疹病毒感染的再激活。我们呈现此病例是因为它发生在接种科瓦克辛疫苗之后。文献中关于接种新冠疫苗后发生带状疱疹的病例报告很少。
我们报告了一名72岁女性在接种第一剂新冠疫苗后发生带状疱疹的病例。她患有带状疱疹后神经痛。
显然，水痘-带状疱疹病毒再激活是新冠疫苗的不良事件之一。然而，开展大规模流行病学研究以核查接种新冠疫苗后带状疱疹的常见程度是明智的。
